Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an update.
ResMed Inc. has reported a change in beneficial ownership as per a Form 4 filing with the SEC, indicating that CEO Michael J. Farrell executed transactions involving the acquisition and disposal of common stock under a pre-established Rule 10b5-1 plan. This transaction reflects the company’s ongoing adherence to regulatory compliance and may impact stakeholders’ perception of executive confidence in the company’s future performance.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders and respiratory care. The company is known for its innovative solutions in sleep apnea treatment and other respiratory conditions, catering to a global market.
YTD Price Performance: -0.68%
Average Trading Volume: 1,062,192
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.39B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com